Skip to content

Clinical study on the effectiveness of Shen Huang ointment and powder on the postoperative ileus (POI) with qi stagnation and blood stasis

Demonstration research on clinical studies of TCM external therapies for perioperative treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000565
Enrollment
Unknown
Registered
2009-10-23
Start date
2009-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative ileus after gastrointestinal tumor operation

Interventions

Shen Huang powder group:Shen Huang ointment spreading umbilicus plus routine treatment
placebo of Shen Huang powder group:placebo of Shen Huang powder spreading umbilicus placebo
placebo of Shen Huang ointment group:placebo of Shen Huang ointment spreading umbilicus + routine treatment
Shen Huang powder group:Shen Huang powder spreading umbilicus plus routine treatment

Sponsors

Traditional Chinese Medicine Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. consecutive patients aged from 40y-75y, either sex; 2. accord with the diagnosis standard(gastrointestinal tumor); 3. the TCM syndrome of the postoperative ileus is identified as qi stagnation and blood stasis; 4. to be approved by the ethic committee and an informed consent form to be signed prior to study; 5. patients underwent radical operation for gastrointestinal tumor under general anesthesia, with postoperative ileus (gastrointestinal dysfunction).

Exclusion criteria

Exclusion criteria: 1. the duration of the operation is less than 2 hours or more than 6 hours; 2. operation is not under general anesthesia; 3. patient combined with cardiovascular, liver, kidney, brain, lung and other serious diseases can't tolerate the operation; 4. patients or the family members' attitude about this study is too sensitive to communicate; 5. the disabled patients according to local medical criteria; 6. prokinetic agents such as metoclopramide and erythromycin are administered; 7. proved or suspected alcohol or drug abused patients; 8. allergic constitution(allergic history of more than more than two food or drugs, and proved allergic to the components of the intervention; 9. patient participating other clinical study or having participated other clinical study in the last five months; 10. with serious complications (bleeding, infection, leak).

Design outcomes

Primary

MeasureTime frame
recovery of normal bowel sound;the first postoperative defecation;postoperative anal exhaust time;postoperative anal exhaust time;

Secondary

MeasureTime frame
scores of TCM symptom;intestinal peristalsis;Gastrointestinal hormones (motilin, somatostatin;

Countries

China

Contacts

Public ContactHuasen Qiu
qhs86@163.com+86 0 13805727122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026